Herpesvirus type 7 infection may play an important role in individuals with a genetic profile of susceptibility to Graves' disease

European Journal of Endocrinology

Volumn 162, Issue 2, 2010, Pages 315-321

  Leite, Janaina Luisa ^a   Bufalo, Natassia Elena ^a   Santos, Roberto Bernardo ^b   Romaldini, João Hamilton ^b   Ward, Laura Sterian ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b PONTIFÍCIA UNIVERSIDADE CATÓLICA DE CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE P1; PROLINE; PROTEIN P53;

ADULT; ARTICLE; AUTOIMMUNITY; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; FEMALE; GENE; GRAVES DISEASE; GSTP1 GENE; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 7; INHERITANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TUMOR SUPPRESSOR GENE;

ADULT; AUTOIMMUNITY; CASE-CONTROL STUDIES; CYCLOPHOSPHAMIDE; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; GRAVES DISEASE; HERPESVIRUS 7, HUMAN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; REGRESSION (PSYCHOLOGY); RISK FACTORS; ROSEOLOVIRUS INFECTIONS; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 75149150441     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0719     Document Type: Article

References (40)

1. Desailloud R & Hober D. Viruses and thyroiditis: an update. Virology Journal 2009 12 5.
2. Lehmann HW, Lutterbüse N, Plentz A, Akkurt I, Albers N, Hauffa BP, Hiort O, Schoenau E & Modrow S. Association of parvovirus B19 infection and Hashimoto's thyroiditis in children. Viral Immunology 2008 21 379-383.
3. Thomas D, Karachaliou F, Kallergi K, Vlachopapadopoulou E, Antonaki G, Chatzimarkou F, Fotinou A, Kaldrymides P & Michalacos S. Herpes virus antibodies seroprevalence in children with autoimmune thyroid disease. Endocrine 2008 33 171-175.
4. Tozzoli R, Barzilai O, Ram M, Villalta D, Bizzaro N, Sherer Y & Shoenfeld Y. Infections and autoimmune thyroid diseases: parallel detection of antibodies against pathogens with proteomic technology. Autoimmunity Reviews 2008 8 112-115.
5. Bach JF. Infections and autoimmune diseases. Journal of Autoimmunity 2005 25 74-80.
6. Bloomfield SF, Stanwell-Smith R, Crevel RW & Pickup J. Too clean, or not too clean: the hygiene hypothesis and home hygiene. Clinical and Experimental Allergy 2006 36 402-425.
7. Davies TF. Infection and autoimmune thyroid disease. Journal of Clinical Endocrinology and Metabolism 2008 93 674-675.
8. Harii N, Lewis CJ, Vasko V, McCall K, Benavides-Peralta U, Sun X, Ringel MD, Saji M, Giuliani C, Napolitano G, Goetz DJ & Kohn LD. Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto's autoimmune thyroiditis. Molecular Endocrinology 2005 19 1231-1250.
9. Chen T & Hudnall SD. Anatomical mapping of human herpesvirus reservoirs of infection. Modern Pathology 2006 19 726-737.
10. Thomas D, Liakos V, Michou V, Kapranos N, Kaltsas G, Tsilivakos V & Tsatsoulis A. Detection of herpes virus DNA in post-operative thyroid tissue specimens of patients with autoimmune thyroid disease. Experimental and Clinical Endocrinology & Diabetes 2008 116 35-39.
11. Krueger GR, Koch B, Leyssens N, Berneman Z, Rojo J, Horwitz C, Sloots T, Margalith M, Conradie JD, Imai S, Urasinski I, de Bruyère M, Ferrer Argote V & Krueger J. Comparison of seroprevalences of human herpesvirus-6 and -7 in healthy blood donors from nine countries. Vox Sanguinis 1998 75 193-197.
12. Harris SL. The p53 pathway: positive and negative feedback loops. Oncogene 2005 24 2899-2908.
13. Takemoto M, Mori Y, Ueda K, Kondo K & Yamanishi K. Productive human herpesvirus 6 infection causes aberrant accumulation of p53 and prevents apoptosis. Journal of General Virology 2004 85 869-879.
14. Øster B, Bundgaard B & Höllsberg P. Human herpesvirus 6B induces cell cycle arrest concomitant with p53 phosphorylation and accumulation in T cells. Journal of Virology 2005 79 1961-1965.
15. Oster B, Bundgaard B, Hupp TR & Höllsberg P. Human herpesvirus 6B induces phosphorylation of p53 in its regulatory domain by a CK2- and p38-independent pathway. Journal of General Virology 2008 89 87-96.
16. Oster B, Kofod-Olsen E, Bundgaard B & Höllsberg P. Restriction of human herpesvirus 6B replication by p53. Journal of General Virology 2008 89 1106-1113.
17. Fenton CL, Patel A, Tuttle RM & Francis GL. Autoantibodies to p53 in sera of patients with autoimmune thyroid disease. Annals of Clinical Laboratory Science 2000 30 179-183.
18. Leite JL, Manfrinatto JA, Mazzali M & Ward LS. Polymorphisms at exon 4 of p53 and the susceptibility to herpesvirus types 6 and 1 infection in renal transplant recipients. Transplant International 2006 19 732-737.
19. Bufalo NE, Santos RB, Cury AN, Andrade RA, Morari J, Morari EC, Leite JL, Monte O, Romaldini JH & Ward LS. Genetic polymorphisms associated with cigarette smoking and the risk of Graves' disease. Clinical Endocrinology 2008 68 982-987.
20. Werner SC. Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. Journal of Clinical Endocrinology and Metabolism 1977 44 203-204.
21. Leite JL, Stolf HO, Reis NA & Ward LS. Human herpesvirus type 6 and type 1 infection increases susceptibility to nonmelanoma skin tumors. Cancer Letters 2005 224 213-219.
22. Chan P, Chan M, Li W, Chan D, Cheung J & Cheng A. Association of human β-herpesviruses with the development of cervical cancer: bystanders or cofactors. Journal of Clinical Pathology 2001 54 48-53.
23. Morari EC, Leite JL, Granja F, Assumpcao LVM & Ward LS. The null genotype of glutathione S-transferase M1 and T1 locus increases the risk for thyroid cancer. Cancer Epidemiology, Biomarkers & Prevention 2002 11 1485-1488.
24. Bufalo NE, Leite JL, Guilhen AC, Morari EC, Granja F, Assumpção LVM & Ward LS. Smoking and susceptibility to thyroid cancer: an inverse association with CYP1A1 allelic variants. Endocrine-Related Cancer 2006 13 1185-1193.
25. Morari EC, Lima AB, Bufalo NE, Leite JL, Granja F & Ward LS. Role of glutathione-S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients. Journal of Cancer Research and Clinical Oncology 2006 132 521-528.
26. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L & Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. Journal of the National Cancer Institute 2004 96 434-442.
27. Muñoz-Fontela C, Garcia MA, Garcia-Cao I, Collado M, Arroyo J, Esteban M, Serrano M & Rivas C. Resistance to viral infection of super p53 mice. Oncogene 2005 24 3059-3062.
28. Yoon YJ, Chang HY, Ahn SH, Kim JK, Park YK, Kang DR, Park JY, Myoung SM, Kim do Y, Chon CY & Han KH. MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Carcinogenesis 2008 29 1192-1196.
29. Bhattacharya P & Sengupta S. Predisposition to HPV16/18-related cervical cancer because of proline homozygosity at codon 72 of p53 among Indian women is influenced by HLA-B*07 and homozygosity of HLA-DQB1*03. Tissue Antigens 2007 70 283-293.
30. Pantelis A, Pantelis D, Ruemmele P, Hartmann A, Hofstaedter F, Buettner R, Bootz F & Stoehr R. p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort. Oncology Reports 2007 17 1243-1248.
31. Granja F, Morari J, Morari EC, Correa LA, Assumpção LV & Ward LS. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Letters 2004 210 151-157.
32. Piotrowski P, Lianeri M, Mostowska M, Wudarski M, Chwalinska-Sadowska H & Jagodzinski PP. Contribution of polymorphism in codon 72 of p53 gene to systemic lupus erythematosus in Poland. Lupus 2008 17 148-151.
33. Macchioni P, Nicoli D, Casali B, Catanoso M, Farnetti E, Boiardi L & Salvarani C. The codon 72 polymorphic variants of p53 in Italian rheumatoid arthritis patients. Clinical and Experimental Rheumatology 2007 25 416-421.
34. den Reijer PM, Maier AB, Westendorp RG & van Heemst D. p53 codon 72 proline/arginine polymorphism and autoimmune thyroid diseases. Journal of Clinical Laboratory Analysis 2008 22 321-326.
35. Garte S. Metabolic susceptibility genes as cancer risk factors: time for a reassessment? Cancer Epidemiology, Biomarkers & Prevention 2001 10 1233-1237.
36. Scotet E, Peyrat MA, Saulquin X, Retiere C, Couedel C, Davodeau F, Dulphy N, Toubert A, Bignon JD, Lim A, Vie H, Hallet MM, Liblau R, Weber M, Berthelot JM, Houssaint E & Bonneville M. Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes. European Journal of Immunology 1999 29 973-985.
37. Posnett DN. Herpesviruses and autoimmunity. Current Opinion in Investigational Drugs 2008 9 505-514.
38. Fountoulakis S & Tsatsoulis A. On the pathogenesis of autoimmune thyroid disease: a unifying hypothesis. Clinical Endocrinology 2004 60 397-409.
39. Inoue Y, Yasukawa M & Fujita S. Induction of T-cell apoptosis by human herpesvirus 6. Journal of Virology 1997 71 3751-3759.
40. Ito T. Overexpression of bcl-2 suppresses apoptosis in the human leukemia cell line TF-1. Rinsho Byori. The Japanese Journal of Clinical Pathology 1997 45 628-637.